Argentina Pharmaceuticals and Healthcare Report Q1 2009

Executive Summary ....................5
Argentina Pharmaceuticals And Healthcare Industry SWOT ........... 6
Argentina Political SWOT ...... 7
Argentina Economic SWOT ................................. 8
Argentina Business Environment SWOT.............. 9
Pharmaceutical Business Environment Ratings ..............................10
Table: Americas Pharmaceutical Business Environment Rankings .............................. 10
Limits Of Potential Returns................................ 10
Risks To Realisation Of Returns ........................ 11
Argentina – Market Summary ................................12
Regulatory Regime....................13
OTC Regulation.................... 13
Recent Regulatory Developments ...................... 14
Intellectual Property (IP) Environment ............. 14
IP Disputes ........................... 17
Table: Joint Declaration By Latin American Health Ministers, May 2006................... 18
Counterfeit Pharmaceuticals ............................. 19
Pricing Regime ..................... 19
Table: Argentina’s Drug Price Freeze, 2005-2008......................... 21
Reimbursement Regime......... 22
Industry Developments.............24
Epidemiology........................ 24
Healthcare Insurance ........... 25
Recent Health Insurance Developments............. 26
Pharmaceutical Sector.......... 27
Multinational Sector Developments ................... 28
Domestic Manufacturing Sector ........................ 30
Vaccines Sector..................... 32
Recent Developments in the Vaccines Sector..... 33
Medicinal Plants................... 36
Table Argentina - Imports of Medicinal Plants by Country (US$'000) ......................... 36
Research and Development (R&D).................... 37
Industry Forecast Scenario .......39
Overall Market Forecast....... 39
Table: Argentina - Drug Market Indicators, 2003-2013 (ARSmn unless otherwise stated) ....................... 40
Key Growth Factors – Industry.......................... 41
Table: Argentina – Health Expenditure Indicators, 2003-2013 (ARSmn unless otherwise stated)............. 42
Key Growth Factors – Macroeconomic ............. 43
Table: Argentina – Economic Activity ............... 45
Prescription Market Forecast ............................ 46
Table: Argentina - Prescription Drug Market Indicators, 2003-2013 (ARSmn unless otherwise stated)... 47
OTC Market Forecasts ......... 48
Table: Argentina – OTC Market Indicators, 2003-2013 (ARSmn unless otherwise stated) ....................... 49
Patented Market Forecast.................................. 50
Table: Argentina – Patented Market Indicators, 2003-2013 (ARSmn unless otherwise stated) ................. 50
Generics Market Forecast ................................. 51
Table: Argentina – Generics Market Indicators , 2003-2013 (ARSmn unless otherwise stated)................ 52
Export/Import Forecasts....... 53
Table Argentina – Imports of Medicines Containing Vitamins by Country (US$'000)............................... 54
Table: Argentina - Import And Export Trade Indicators, 2003-2013 (US$mn) ............ 55
Medical Device Market Forecast....................... 56
Table: Argentina – Medical Device Market Forecast, 2004-2013 (ARSmn unless otherwise stated)........ 58
Other Healthcare Data Forecasts...................... 59
Table: Argentina – Other Health Indicators, 2003-2013 ................ 59
Key Risks To BMI’s Forecast Scenario.............. 59
Competitive Landscape............60
Company Monitor......................61
Leading Foreign Companies...... 61
Pfizer ....... 61
Roche....... 63
Novartis ................................ 65
GlaxoSmithKline (GSK)........ 67
Sanofi-Aventis....................... 69
Merck & Co .......................... 71
Boehringer Ingelheim ........... 73
Indigenous Manufacturers ......... 74
Laboratorios Roemmers........ 74
Laboratorios Bagó................ 76
Country Snapshot: Argentina Demographic Data ............................79
Section 1: Population............ 79
Table: Demographic Indicators, 2005-2030...... 79
Table: Rural/Urban Breakdown, 2005-2030 ..... 80
Section 2: Education And Healthcare................ 80
Table: Education .................. 80
Table: Life Expectancy, 2005-2030 ................... 80
Section 3: Labour Market And Spending Power ............................. 81
Table: Employment Indicators, 2001-2006........ 81
Table: Consumer Expenditure, 2000-2012 (US$) ........................... 81
Table: Average Annual Manufacturing Wages, 1995-2001 ............ 82
BMI Forecast Modelling............83
How We Generate Our Pharmaceutical Industry Forecasts ................ 83
Pharmaceutical Business Environment Ratings Methodology ............. 84
Ratings Overview.................. 84
Table: Pharmaceutical Business Environment Indicators .............. 85
Weighting.............................. 86
Table: Weighting Of Components...................... 86
Sources ......... 86